GlassScriptPhysician profile
Scott Haupt
NPI 1508877119
$1,213.85
in general payments reported to CMS, 2019-2025
15 companies · $89.69 in 2025
The $89.69 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $556 · 2020: $45.09 · 2021: $31.93 · 2022: $31.06 · 2023: $220 · 2024: $240 · 2025: $89.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $549.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $549.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $185.75 | 2019-2023 | Durasorb Monofilament Mesh |
| Tepha INC | $178.77 | 2019 | |
| Abbvie INC. | $168.35 | 2023-2025 | |
| Allergan, INC. | $142.88 | 2019-2021 | |
| Mentor Worldwide LLC | $123.08 | 2019-2022 | |
| Tela Bio, INC. | $106.30 | 2024 | Ovitex 2s |
| Merz North America, INC. | $77.63 | 2019 | |
| Motiva USA, LLC | $66.06 | 2025 | |
| Galderma Laboratories, L.P. | $40.38 | 2019-2023 | |
| Sientra, INC. | $32.65 | 2020 | |
| Acell, INC. | $30.24 | 2019 | |
| Solta Medical, A Division of Bausch Health US, LLC | $21.23 | 2023 | |
| Coopersurgical, INC. | $15.86 | 2024 | Insorb |
| Smith+Nephew, INC. | $15.18 | 2021 | |
| Polarityte, INC. | $9.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Haupt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.